Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials
Arman Shafiee, Kyana Jafarabady, Niloofar Seighali, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 25
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Konstantinos Ν. Fountoulakis, Athanasios Saitis, Alan F. Schatzberg
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 8
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults
Ellen Van Leeuwen, Mieke L van Driel, Mark Horowitz, et al.
Cochrane library (2021) Vol. 2021, Iss. 4
Open Access | Times Cited: 76
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Adele Framer
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 56
Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies
Mark Horowitz, David Taylor
BJPsych Advances (2022) Vol. 28, Iss. 5, pp. 297-311
Open Access | Times Cited: 47
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Mark Horowitz, Adele Framer, Michael P. Hengartner, et al.
CNS Drugs (2022) Vol. 37, Iss. 2, pp. 143-157
Open Access | Times Cited: 46
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Anne Guy, Marion Brown, Stevie Lewis, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 61
May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance
Giovanni A. Fava
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 59
Xiaoyaosan promotes neurotransmitter transmission and alleviates CUMS-induced depression by regulating the expression of Oct1 and Oct3 in astrocytes of the prefrontal cortex
Yayun Wu, Li‐Juan Liu, Ya Zhao, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117923-117923
Closed Access | Times Cited: 6
Können Antidepressiva den langfristigen Verlauf depressiver Erkrankungen negativ verändern?
Gerhard Gründer, Lea J. Mertens, Moritz Spangemacher, et al.
Der Nervenarzt (2025)
Closed Access
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study
Peter C. Groot, Jim van Os
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 26
Alterations in gut microbiota caused by major depressive disorder or a low FODMAP diet and where they overlap
Simone O’Neill, Michelle Minehan, Catherine R. Knight‐Agarwal, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 3
Antidepressant prescribing in Australian primary care: time to reevaluate
Katharine Wallis, Anna King, Joanna Moncrieff
The Medical Journal of Australia (2025)
Open Access
Protocol to evaluate the effectiveness of the implementation of transdiagnostic cognitive behavioural therapy for emotional disorders in primary care and its mechanisms of change: a randomized step-wedge clinical trial (PsicAP-CV)
Roger Muñoz‐Navarro, Virtudes Pérez‐Jover, Gabriel Esteller-Collado, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320857-e0320857
Open Access
Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications
Kunying Zhao, Yuxiao Zhang, Shuda Yang, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
A systematic review of manipulations to pharmaceutical dosage forms used in psychotropic tapering plans
Denis O’Brien, Anne Marie Healy, Andrew Harkin, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Antidepressant Trial Duration Versus Duration of Real-World Use: A Systematic Analysis
William Ward, Alyson Haslam, Vinay Prasad
The American Journal of Medicine (2025)
Open Access
A review on the validity of animal models for neuropsychiatric disorders: an exploration of anhedonia
Kate M. Witt, David N. Harper, Bart Ellenbroek
Behavioural Pharmacology (2025) Vol. 36, Iss. 4, pp. 165-170
Closed Access
Outcome of antidepressant drug discontinuation with taperingstrips after 1–5 years
Peter C. Groot, Jim van Os
Therapeutic Advances in Psychopharmacology (2020) Vol. 10, pp. 204512532095460-204512532095460
Open Access | Times Cited: 25
Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop
Mark Horowitz, Michael Wilcock
Drug and Therapeutics Bulletin (2021) Vol. 60, Iss. 1, pp. 7-12
Closed Access | Times Cited: 22
Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses
Sebastian Reyes-Lizaola, Ulises Luna-Zarate, Hiram Tendilla‐Beltrán, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 129, pp. 110876-110876
Closed Access | Times Cited: 9
Discontinuing psychotropic drug treatment
Leonardo Tondo, Ross J. Baldessarini
BJPsych Open (2020) Vol. 6, Iss. 2
Open Access | Times Cited: 21
Interventions Addressing Depression and HIV-Related Outcomes in People with HIV
Noelle A. Mendez, Daniel Mayo, Steven A. Safren
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 4, pp. 377-390
Open Access | Times Cited: 18
Targeting the Endoplasmic Reticulum Stress-Linked PERK/GRP78/CHOP Pathway with Magnesium Sulfate Attenuates Chronic-Restraint-Stress-Induced Depression-like Neuropathology in Rats
Hany H. Arab, Ali Khames, Shuruq E. Alsufyani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 300-300
Open Access | Times Cited: 8
RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice
Katharine Wallis, Maria Donald, Mark Horowitz, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top